Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 109.21 |
| Open | 107.53 |
| Bid | 106.00 x 1300 |
| Ask | 106.20 x 800 |
| Day's Range | 104.25 - 108.72 |
| 52 Week Range | 89.67 - 121.64 |
| Volume | |
| Avg. Volume | 5,858,533 |
| Market Cap | 189.5B |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | 32.39 |
| EPS (TTM) | 3.27 |
| Earnings Date | Apr 17, 2024 |
| Forward Dividend & Yield | 2.20 (2.01%) |
| Ex-Dividend Date | Apr 12, 2024 |
| 1y Target Est | 126.74 |
- Yahoo Finance Video
Abbott Labs posts Q1 earnings beat
Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range. Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
Investor's Business DailyAbbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but Abbott stock slipped.
ZacksAbbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
© 2024 Yahoo. All rights reserved.